Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India

Authors

  • Hitt J Sharma Serum Institute of India Ltd., Pune-411028, India
  • Vasant S Padbidri King Edward Memorial Hospital Research Centre, Pune-411011, India
  • Subhash V Kapre Serum Institute of India Ltd., Pune-411028, India
  • Suresh S Jadhav Serum Institute of India Ltd., Pune-411028, India
  • Rajeev M Dhere Serum Institute of India Ltd., Pune-411028, India
  • Sameer S Parekh Serum Institute of India Ltd., Pune-411028, India
  • Ashok D Dudhane King Edward Memorial Hospital Research Centre, Pune-411011, India
  • Sunil D Shewale Serum Institute of India Ltd., Pune-411028, India
  • Gajanan S Namjoshi Earlier with Serum Institute of India Ltd., Pune-411028, India

DOI:

https://doi.org/10.3855/jidc.1847

Keywords:

rubella, serological survey, immunogenicity, safety

Abstract

Introduction: Serologic surveys conducted in different countries indicate that rubella is a worldwide infection.Several such sero surveys conducted in India have also confirmed that 6-47% of women are susceptible to rubella infection. The current study was conducted on 1,329 female adolescents in 12 districts of Maharashtra, India, to assess their serological status in terms of rubella exposure.

Methodology: After enrollment, a pre-vaccination blood sample was collected from the participants followed by rubella vaccination (R-vac). Adverse events were monitored for the next 6-8 weeks, at which time a post-vaccination sample was collected.

Results: Pre-vaccination rubella immunity was higher in the urban (80.2%) population compared to the rural (73.1%) population. Following R-vac vaccination, out of 1,159 participants who completed the study, all (100%) in the urban and 99.5% of participants in the rural area developed antibodies against rubella.

Conclusion: Substantial numbers of women reach childbearing age without immunity against rubella and thus are at a risk of passing the infection to their fetuses, who can then develop subsequent congenital defects leading to congenital rubella syndrome (CRS). An immunization policy recommending vaccination with rubella or rubella containing vaccine is highly desirable to prevent rubella and CRS. 

Author Biographies

Hitt J Sharma, Serum Institute of India Ltd., Pune-411028, India

Deputy Medical Director, Medical Affairs Department, Serum Institute of India ltd., Pune

Vasant S Padbidri, King Edward Memorial Hospital Research Centre, Pune-411011, India

Director, KEM Hospital and Research Centre, Pune

Subhash V Kapre, Serum Institute of India Ltd., Pune-411028, India

Executive Director, Research and Development, Serum Institute of India ltd., Pune

Suresh S Jadhav, Serum Institute of India Ltd., Pune-411028, India

Executive Director, Regulatory Affairs, Serum Institute of India ltd., Pune

Rajeev M Dhere, Serum Institute of India Ltd., Pune-411028, India

Senior Director, MMR Production department, Serum Institute of India ltd., Pune

Sameer S Parekh, Serum Institute of India Ltd., Pune-411028, India

Manager, Medical affairs Department, Serum Institute of India ltd., Pune

Ashok D Dudhane, King Edward Memorial Hospital Research Centre, Pune-411011, India

Research Officer, KEM Hospital and Research Centre, Pune

Sunil D Shewale, Serum Institute of India Ltd., Pune-411028, India

Clinical Research Associate, Medical affairs Department, Serum Institute of India ltd., Pune

Gajanan S Namjoshi, Earlier with Serum Institute of India Ltd., Pune-411028, India

Assistant Director, Serum Institute of India ltd., Pune

Downloads

Published

2011-11-08

How to Cite

1.
Sharma HJ, Padbidri VS, Kapre SV, Jadhav SS, Dhere RM, Parekh SS, Dudhane AD, Shewale SD, Namjoshi GS (2011) Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. J Infect Dev Ctries 5:874–881. doi: 10.3855/jidc.1847

Issue

Section

Original Articles